BRIEF published on 11/06/2025 at 13:05, 4 months 20 days ago Moderna annonce un chiffre d'affaires d'un milliard de dollars au troisième trimestre 2025, malgré des prévisions financières revues à la baisse pour 2025. Résultats Financiers Moderna Baisse Des Revenus Vaccin Contre Le Covid-19 Efficacité En Matière De Coûts
PRESS RELEASE published on 11/06/2025 at 13:00, 4 months 20 days ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 4 months 23 days ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
BRIEF published on 11/03/2025 at 13:05, 4 months 23 days ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
PRESS RELEASE published on 11/03/2025 at 13:00, 4 months 23 days ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 5 months 3 days ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 5 months 3 days ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 5 months 3 days ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 5 months 3 days ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
BRIEF published on 10/23/2025 at 13:05, 5 months 3 days ago Moderna to Host Investor Event on November 20, 2025 Webcast MRNA Technology Moderna Investor Event Analyst Day
Published on 03/26/2026 at 23:00, 9 hours 5 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 10 hours ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 10 hours 5 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 10 hours 5 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 11 hours 5 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/27/2026 at 07:45, 20 minutes ago Pyrum Innovations AG publishes preliminary results for financial year 2025
Published on 03/27/2026 at 07:30, 35 minutes ago DKSH Performance Materials Acquires AIC Ingredients, a Leading Customized Food Solutions Manufacturer in Malaysia
Published on 03/27/2026 at 07:30, 35 minutes ago Haier Celebrates Excellence in Paris With New Smart Home Portfolio
Published on 03/27/2026 at 07:00, 1 hour 5 minutes ago Edisun Power Europe AG: Demanding year reinforces the urgency of advancing the ‘Renewables to AI’ strategy
Published on 03/27/2026 at 07:00, 1 hour 5 minutes ago Edisun Power Europe AG: Résultat annuel difficile soulignent la nécessité de la nouvelle stratégie « Renewables to AI »
Published on 03/27/2026 at 07:00, 1 hour 5 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 13 hours 48 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 13 hours 48 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 14 hours 5 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
